-
Mashup Score: 0Alzheimer Disease as a Clinical-Biological Construct - 7 hour(s) ago
This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and…
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 103Alzheimer Disease as a Clinical-Biological Construct - 2 day(s) ago
This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and…
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet-
International Working Group suggests biomarker positive cognitively normal individuals should not be diagnosed as having Alzheimer disease and instead are at-risk. https://t.co/MLPCp4qQJB #CTAD24 https://t.co/GnfbyjJlF2
-
-
Mashup Score: 8Alzheimer Disease as a Clinical-Biological Construct - 5 day(s) ago
Interview with Giovanni B. Frisoni, MD, author of Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation. Hosted by Cynthia E. Armand, MD.
Source: edhub.ama-assn.orgCategories: General Medicine News, NeurologyTweet-
Author @GiovanniFrisoni discusses "Alzheimer Disease Is a Clinical-Biological Construct: An IWG Recommendation" with JAMA Neurology Web Editor @cynarmandmd. https://t.co/wmqk5LILNj #CTAD24
-
-
Mashup Score: 16Alzheimer Disease—What’s in a Name? - 5 day(s) ago
In this issue of JAMA Neurology, the International Work Group (IWG) responds to the recently published 2024 Alzheimer Association (AA) Diagnostic Framework for Alzheimer Disease (AD) with their own framework and views.1 Back in 2018, the National Institute on Aging (NIA)–AA group proposed a…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
From @JAMANeuro: Editorial: Alzheimer Disease—What’s in a Name? #CTAD24 https://t.co/gPkVFtjbZa https://t.co/r8Wu0tlStV
-
-
Mashup Score: 32Alzheimer Disease—What’s in a Name? - 5 day(s) ago
In this issue of JAMA Neurology, the International Work Group (IWG) responds to the recently published 2024 Alzheimer Association (AA) Diagnostic Framework for Alzheimer Disease (AD) with their own framework and views.1 Back in 2018, the National Institute on Aging (NIA)–AA group proposed a…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
From @JAMANeuro: Editorial: Alzheimer Disease—What’s in a Name? #CTAD24 https://t.co/whT1Z5cEAY https://t.co/mw6Xw5NzGq
-
-
Mashup Score: 168Alzheimer Disease—What’s in a Name? - 5 day(s) ago
In this issue of JAMA Neurology, the International Work Group (IWG) responds to the recently published 2024 Alzheimer Association (AA) Diagnostic Framework for Alzheimer Disease (AD) with their own framework and views.1 Back in 2018, the National Institute on Aging (NIA)–AA group proposed a…
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet-
Editorial: Alzheimer Disease—What’s in a Name? #CTAD24 https://t.co/x41u0uuOSG https://t.co/0RnxqK6KAP
-
-
Mashup Score: 28Alzheimer Disease as a Clinical-Biological Construct - 5 day(s) ago
This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
From @JAMANeuro: International Working Group suggests biomarker positive cognitively normal individuals should not be diagnosed as having Alzheimer disease and instead are at-risk. #CTAD24 https://t.co/ebRWBhgIZk https://t.co/Iz8xGR1nkj
-
-
Mashup Score: 193Alzheimer Disease as a Clinical-Biological Construct - 5 day(s) ago
This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and…
Source: jamanetwork.comCategories: General Medicine News, NeurologyTweet-
International Working Group suggests biomarker positive cognitively normal individuals should not be diagnosed as having Alzheimer disease and instead are at-risk. https://t.co/PfrkTJwZKi #CTAD24 https://t.co/vGiFLfsdHv
-
-
Mashup Score: 100Alzheimer Disease as a Clinical-Biological Construct - 5 day(s) ago
This Special Communication discusses a recent revision of the Alzheimer Association (AA) criteria to define Alzheimer disease (AD) as a purely biological entity, which raises concerns that if diagnosis of AD can be reduced to the sole presence of AD core 1 biomarkers, major uncertainty and…
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
From @JAMANeuro: International Working Group suggests biomarker positive cognitively normal individuals should not be diagnosed as having Alzheimer disease and instead are at-risk. #CTAD24 https://t.co/ACYx6gqxE8 https://t.co/kHfFsZraFo
-
-
Mashup Score: 4
The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.
Source: investor.lilly.comCategories: General Medicine News, PayerTweet-
News for people living with Alzheimer’s disease: Today we presented new research at #CTAD24 on a treatment option for adults with early symptomatic Alzheimer’s disease. https://t.co/n5V1Me7Gmw https://t.co/YoFB8Yt1Et
-
International Working Group suggests biomarker positive cognitively normal individuals should not be diagnosed as having Alzheimer disease and instead are at-risk. https://t.co/4E4sc0nLdv #CTAD24 https://t.co/IPwkRGs50b